C.R. Bard Transvaginal Mesh Lawsuits Move Forward With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing hundreds of women who allegedly suffered serious vaginal mesh complications following implantation of pelvic mesh devices marketed by C.R. Bard, Inc. and other companies.

Free Case Review
Our Firm has filed a number of transvaginal mesh lawsuits in this proceeding. We are pleased to see that it is moving forward.

Thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against C.R. Bard continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order issued on June 19, 2014, the Court has directed the parties to provide certain identifying information, including which C.R. Bard mesh products a plaintiff has received, for a number of vaginal mesh lawsuits pending in the proceeding. The information is to be submitted to the Court on or before June 26, 2014. (MDL No. 2187)

“Our Firm has filed a number of transvaginal mesh lawsuits in this proceeding. We are pleased to see that it is moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free transvaginal mesh lawsuit consultations to women who allegedly suffered serious complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.

Transvaginal Mesh Litigation
Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for the federal C.R. Bard litigation. Court documents indicate that more than 8,500 product liability claims have been filed in the proceeding on behalf of women who allegedly suffered mesh erosion, chronic pain, scarring, infections, organ damage, and other serious vaginal mesh complications caused by surgical implants used to treat pelvic organ prolapse and stress urinary incontinence. All of the claims pending against C.R. Bard in the Southern District of West Virginia accuse the company of failing to subject its pelvic mesh products to adequate testing to ensure safety and effectiveness, and of failing to provide doctors and patients with appropriate warnings regarding their risks.

According to court records, nearly 60,000 transvaginal mesh lawsuits that make similar allegations have been filed in the Southern District of West Virginia against a number of medical device manufacturers. Mr. Grand is also a member of the Plaintiffs’ Steering Committees in proceedings involving American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and Ethicon, Inc. (MDL No. 2327).

Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Alleged victims of serious vaginal mesh complications may be entitled to file their own lawsuit to obtain compensation for their injury-related damages. To learn more about the ongoing transvaginal mesh litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To arrange for a free, no obligation case review, please contact the Firm today at 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern